Tue, Sep 30, 2014, 3:45 PM EDT - U.S. Markets close in 15 mins.

Recent

% | $
Quotes you view appear here for quick access.

Opexa Therapeutics, Inc. (OPXA) Message Board

  • rrtzrealmd rrtzrealmd Feb 5, 2013 10:02 AM Flag

    HAW!!!...gotta love it!...

    ..."Potential payments to Opexa from the option and license agreement could total $225 million based upon the successful development and commercialization of Tcelna for MS."...HAW!!!...

    ...that's rich!!...of course, OPXA only gets 5 million dollars initially to conduct their trial...

    ...and given that OPXA was begging to get even $650,000 a couple of weeks ago just to stay listed, you figure that they don't have very deep pockets...

    ...and in practcial terms, 5 million dollars will be barely enough to pay management salaries for a few more months, much less pay for a phase 2 trial...

    ...and given that Tovaxin...now renamed "Tcelna" -- that is much more hip, don't you thin...HAW!!!...

    ...anyway, as I was saying, given the past overwhelming successes of tovaxin -- does anyone smell the scent of sarcasm here -- I really don't think OPXA anything beyond that 5 million...

    ...but at least management gets to keep their fat salaries, benefits, bonuses, and perks for a little while longer...and after all, when you're a biotech, that's what really counts -- right?...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OPXA
0.9832+0.0287(+3.01%)3:45 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.